Latest American Mental and Medical Health News Thread, EnVivo Announces Positive Phase 2b Clinical Data In Schizophrenia in Informational; EnVivo Pharmaceuticals announced today positive topline results of its randomized, placebo-controlled Phase 2b clinical trial of EVP-6124, its potent, orally ...
-
May 17th, 2011, 11:50 AM
#1
EnVivo Announces Positive Phase 2b Clinical Data In Schizophrenia
EnVivo Pharmaceuticals announced today positive topline results of its randomized, placebo-controlled Phase 2b clinical trial of EVP-6124, its potent, orally bioavailable and selective alpha-7 agonist, in patients with schizophrenia...
More...
Posting Permissions
- You may not post new threads
- You may not post replies
- You may not post attachments
- You may not edit your posts
-
Forum Rules
LinkBack URL
About LinkBacks
Senior Member
Reply With Quote